Imitrex and Meloxicam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imitrex (sumatriptan succinate) and Meloxicam (meloxicam). Common drug interactions include tremor among females and dyspepsia among males.

The phase IV clinical study analyzes what interactions people have when they take Imitrex and Meloxicam. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Imitrex?

Imitrex has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 17,149 Imitrex users. Check the latest studies of Imitrex.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,017 Meloxicam users. Check the latest studies of Meloxicam.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

85 people who take Imitrex and Meloxicam together, and have interactions are studied.

Imitrex and Meloxicam drug interactions.

What are the common drug interactions of Imitrex and Meloxicam, by gender? *:

female:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Vomiting
  3. Abdominal pain
  4. Cough
  5. Drug hypersensitivity
  6. Ear discomfort
  7. Hyposmia (impairment of the sense of smell)
  8. Injection site swelling
  9. Muscular weakness (muscle weakness)
  10. Neck pain

male:

  1. Dyspepsia (indigestion)
  2. Fall
  3. Anaemia macrocytic (a macrocytic class of anaemia)
  4. Ankle fracture
  5. Arthralgia (joint pain)
  6. Back disorder
  7. Back pain
  8. Bleeding time prolonged
  9. Blood calcium increased
  10. Blood iron decreased

What are the common drug interactions of Imitrex and Meloxicam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Injection site bruising
  2. Anxiety
  3. Atelectasis (partial or complete collapse of the lung)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Chills (felling of cold)
  6. Decreased interest
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Depression
  9. Device dislocation
  10. Dyspnoea (difficult or laboured respiration)

30-39:

  1. Dizziness
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Attention deficit/hyperactivity disorder
  4. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  5. Dyspnoea (difficult or laboured respiration)
  6. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  7. Incision site pain
  8. Insomnia (sleeplessness)
  9. Interstitial lung disease
  10. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

40-49:

  1. Dyspepsia (indigestion)
  2. Nausea (feeling of having an urge to vomit)
  3. Dysarthria (speech disorder)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Headache (pain in head)
  6. Loss of consciousness
  7. Pancreatitis (inflammation of pancreas)
  8. Pancreatitis acute (sudden inflammation of pancreas)
  9. Pyrexia (fever)
  10. Renal injury (kidney injury)

50-59:

  1. Drug hypersensitivity
  2. Drug ineffective
  3. Dry mouth
  4. Encephalitis herpes (inflammation of the brain due to herpes infection)
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Flushing (the warm, red condition of human skin)
  7. Gait disturbance
  8. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  9. Joint injury
  10. Leukocytosis (increased white blood cells)

60+:

  1. Foot fracture
  2. Vitamin d deficiency
  3. Deafness
  4. Dizziness
  5. Ear discomfort
  6. Fatigue (feeling of tiredness)
  7. Headache (pain in head)
  8. Hyposmia (impairment of the sense of smell)
  9. Lethargy (tiredness)
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

  1. Pain: 25 people, 29.41%
  2. Fibromyalgia (a long-term condition which causes pain all over the body): 14 people, 16.47%
  3. High Blood Pressure: 12 people, 14.12%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 11.76%
  5. Depression: 10 people, 11.76%
  6. Headache (pain in head): 8 people, 9.41%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 9.41%
  8. Bone Disorder: 8 people, 9.41%
  9. Hypersensitivity: 7 people, 8.24%
  10. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 7.06%

* Approximation only. Some reports may have incomplete information.

Do you take Imitrex and Meloxicam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imitrex and Meloxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imitrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Meloxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imitrex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meloxicam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and meloxicam (the active ingredients of Imitrex and Meloxicam, respectively), and Imitrex and Meloxicam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: